Industry Analysis & Industry Trends
While this growing industry has been experiencing strong internal and external competition, the patent expirations of several brand-name drugs will create growth opportunities in the short term. Furthermore, healthcare reform will benefit the industry, with more consumers gaining insurance coverage for prescription drugs, improved generic drug approval processes and an established pathway to approval for biosimilars. As in the past five years, manufacturers will also pursue opportunities in biosimilars and emerging markets... purchase to read more
Industry Report - Industry Products Chapter
In 2013, pharmaceutical preparations are expected to account for about 75.1% of industry revenue, a slight decline compared to 78.0% in 2008. The decline is entirely due to the growth of generic biologics. Preparations make up the largest product segment and include drugs that are ready-made for use, such as those in the form of ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. Prescription drug manufacturers and over-the-counter (OTC) pharmaceutical companies make them. Products in this segment are distributed to two primary lines: professionals in the dental, medical or veterinary fields and the general public... purchase to read more